Kingsview Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,819
Closed -$219K 1109
2024
Q4
$219K Sell
2,819
-2,303
-45% -$171K ﹤0.01% 1027
2024
Q3
$343K Sell
5,122
-9,002
-64% -$739K 0.01% 837
2024
Q2
$1.6M Sell
14,124
-756
-5% -$95.6K 0.04% 400
2024
Q1
$2.06M Buy
14,880
+613
+4% +$77.1K 0.05% 334
2023
Q4
$1.77M Buy
+14,267
New +$1.46M 0.05% 309
2023
Q3
Sell
-1,731
Closed -$222K 951
2023
Q2
$222K Buy
+1,731
New +$209K 0.01% 829
2022
Q3
Sell
-2,732
Closed -$204K 831
2022
Q2
$204K Sell
2,732
-32,696
-92% -$2.98M 0.01% 762
2022
Q1
$4.53M Sell
35,428
-16,940
-32% -$1.85M 0.2% 117
2021
Q4
$7.03M Buy
52,368
+3,120
+6% +$448K 0.29% 75
2021
Q3
$6.73M Buy
49,248
+3,176
+7% +$401K 0.32% 67
2021
Q2
$4.92M Buy
46,072
+10,136
+28% +$973K 0.24% 89
2021
Q1
$3.28M Buy
35,936
+15,676
+77% +$1.47M 0.19% 123
2020
Q4
$1.87M Buy
+20,260
New +$1.81M 0.14% 169

Other funds holding DXCM

Kingsview Wealth Management's DXCM Position: Q1 2025 in Review

Kingsview Wealth Management sold out of DexCom (DXCM) in Q1 2025, closing a stake of 2,819 shares — an estimated $219K sold.

Kingsview Wealth Management first reported a position in DXCM in Q4 2020 and held it in 13 quarters. The position peaked at $7.03M in Q4 2021. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Kingsview Wealth Management reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Kingsview Wealth Management sold 2,819 DexCom shares in Q1 2025, an estimated $219K.
  • Kingsview Wealth Management first reported a position in DexCom in Q4 2020 and held it in 13 quarters.
  • Kingsview Wealth Management's DexCom position peaked at $7.03M in Q4 2021.
  • 932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Kingsview Wealth Management's 13F filing for Q1 2025, filed 2 May 2025.